Russell Investments Group’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Russell Investments Group’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-69,351	Closed	-$263K	–	2993
2022 Q1	$263K	Hold	69,351	–	–	﹤0.01%	2403
2021 Q4	$312K	Hold	69,351	–	–	﹤0.01%	2595
2021 Q3	$323K	Hold	69,351	–	–	﹤0.01%	2625
2021 Q2	$488K	Hold	69,351	–	–	﹤0.01%	2605
2021 Q1	$409K	Sell	69,351 -8,738	-11%	-$52.9K	﹤0.01%	2602
2020 Q4	$359K	Buy	+78,089	New	+$337K	﹤0.01%	2555

Other funds holding STSA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Russell Investments Group's STSA Position: Q2 2022 in Review

Russell Investments Group sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2022, closing a stake of 69,351 shares — an estimated $263K sold.

Russell Investments Group first reported a position in STSA in Q4 2020 and held it in 6 quarters. The position peaked at $488K in Q2 2021. 32 funds tracked by Wall St. Rank hold STSA as of Q2 2022.

Russell Investments Group reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Russell Investments Group sold 69,351 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $263K.
Russell Investments Group first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
Russell Investments Group's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $488K in Q2 2021.
32 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Russell Investments Group's 13F filing for Q2 2022, filed 29 Jul 2022.